Headquartered in Burlington, Canada, EKO International Corp. operates via its joint venture with NeuroVasc Clinical Inc. This partnership is responsible for the marketing and supply of frequency rhythmic electrical modulation system (FREMS) equipment throughout Canada, used in addressing peripheral neuropathy. Moreover, through the same joint venture, the company is involved in establishing and managing clinical facilities that provide patient care utilizing FREMS technology.
—
Headquartered in Burlington, Canada, EKO International Corp. operates via its joint venture with NeuroVasc Clinical Inc. This partnership is responsible for the marketing and supply of frequency rhythmic electrical modulation system (FREMS) equipment throughout Canada, used in addressing peripheral neuropathy. Moreover, through the same joint venture, the company is involved in establishing and managing clinical facilities that provide patient care utilizing FREMS technology.
—
Daily adjusted close
Headquartered in Burlington, Canada, EKO International Corp. operates via its joint venture with NeuroVasc Clinical Inc. This partnership is responsible for the marketing and supply of frequency rhythmic electrical modulation system (FREMS) equipment throughout Canada, used in addressing peripheral neuropathy. Moreover, through the same joint venture, the company is involved in establishing and managing clinical facilities that provide patient care utilizing FREMS technology.